Comparison between Jay Jalaram Technologies IPO and JFL Life Sciences IPO.
Jay Jalaram Technologies IPO is a SME Fixed Price IPO proposed to list at NSE SME while JFL Life Sciences IPO is a SME Fixed Price proposed to list at NSE SME.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Econo Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Jay Jalaram Technologies IPO is up to ₹10.26 Cr whereas the issue size of the JFL Life Sciences IPO is up to ₹17.25 Cr. The final issue price of Jay Jalaram Technologies IPO is ₹36.00 per share and of JFL Life Sciences IPO is ₹61.00 per share.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹36.00 per share | ₹61.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 2000 shares |
| Fresh Issue Size | 28,50,000 shares | 28,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹10.26 Cr | up to ₹17.25 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 28,50,000 shares | 28,28,000 shares |
| Issue Size Total (Amount) | up to ₹10.26 Cr | up to ₹17.25 Cr |
Jay Jalaram Technologies IPO opens on Aug 26, 2022, while JFL Life Sciences IPO opens on Aug 25, 2022. The closing date of Jay Jalaram Technologies IPO and JFL Life Sciences IPO is Aug 30, 2022, and Aug 30, 2022, respectively.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 26, 2022 | Aug 25, 2022 |
| Issue Close | Aug 30, 2022 | Aug 30, 2022 |
| Basis Of Allotment (Tentative) | Sep 05, 2022 | Sep 05, 2022 |
| Initiation of Refunds (Tentative) | Sep 06, 2022 | Sep 06, 2022 |
| Credit of Share (Tentative) | Sep 07, 2022 | Sep 07, 2022 |
| Listing date (Tentative) | Sep 08, 2022 | Sep 08, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Jay Jalaram Technologies IPO P/E ratio is 46, as compared to JFL Life Sciences IPO P/E ratio of 26.52.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 92.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.04 | 67.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 46 | 26.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹40.07 Cr. | ₹67.09 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15.72 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.36 | ₹0.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 8.16 | 7.89 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Jay Jalaram Technologies IPO Retail Individual Investors (RII) are offered 14,25,000 shares while in JFL Life Sciences IPO retail investors are offered 14,25,000 shares. Qualified Institutional Buyers (QIB) are offered in Jay Jalaram Technologies IPO and in JFL Life Sciences IPO.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,50,000 shares | 1,50,000 shares |
| QIB | ||
| NII | 14,25,000 shares | 14,14,000 shares |
| RII | 14,25,000 shares | 14,14,000 shares |
| Employee | ||
| Others | ||
| Total | 28,50,000 shares | 28,28,000 shares |
Jay Jalaram Technologies IPO subscribed 14.97x in total, whereas JFL Life Sciences IPO subscribed 8.93x.
| Jay Jalaram Technologies IPO | JFL Life Sciences IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 18.56x | 6.19x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.38x | 11.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 14.97x | 8.93x |
